Smart + Strong.
All Rights Reserved.
Smart + Strong®
is a registered trademark of CDM Publishing, LLC.
Hepato Kit was approved for patients with uveal melanoma that has spread to the liver.
Today, more than half of patients diagnosed with advanced melanoma and treated with new therapies are alive five years after diagnosis.
Basic, translational and clinical research improves, extends and saves lives.
This is the first investigational therapy in a Phase III trial to improve overall survival in uveal melanoma,” a cancer of the eye.
Kimmtrak, the first approved bispecific T-cell engager, improved overall survival in a clinical trial.
Researchers explored challenges and opportunities for research on rare melanomas at the 2021 Melanoma Research Alliance Scientific Retreat.
There’s no FDA-approved treatment for uveal, or eye, melanoma, but a new immunotherapy and molecular therapy show encouraging results.
Findings suggest that UV exposure is unlikely associated with an increased risk of developing melanoma in individuals with skin of color.
The Melanoma Research Alliance shares the top five items that has our team excited for the coming year in the fight against melanoma.
After her own diagnosis, Melody Burchett founded A Cure In Sight, a non-profit organization raising ocular melanoma awareness.
Uveal melanoma occurs when melanin-producing cells form tumors in the eye, and is very different from cutaneous (skin) melanoma.
Doctors are perplexed by the dozens of cases of ocular melanoma in North Carolina and Alabama.
The Cancer Genome Atlas, caretakers, patient advocacy
You have been inactive for 60 minutes and will be logged out in . Any updates not saved will be lost.
Click here to log back in.